Clinical Trial Update: A Study of RAY1225 in Participants With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of RAY1225 in people with Type 2 Diabetes Mellitus is currently active but not recruiting, sponsored by Guangdong Raynovent Biotech Co.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RAY1225

Snippet

Sponsor: Guangdong Raynovent Biotech Co., Ltd | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 2 | Status: ACTIVE_NOT_RECRUITING